INTRODUCTION
Crohn's disease is a chronic inflammatory disease with transmural and patchy involvement of the gastrointestinal tract. Between 17-50% of the time, it presents itself with perianal involvement, mainly in the form of a fistula. 1 The development of mucinous adenocarcinoma within these fistulas is highly unlikely and its diagnosis is difficult as it can be masked by the inflammatory disease. [1] [2] [3] [4] This tumor is usually locally aggressive, and it has poor prognosis, especially if there is a local recurrence. which a mucinous cyst with an abscess is observed and extirpated. Histological examination reveals mucinous pseudocyst.
Figure 1: Abdominopelvic MR. (A) Sagittal plane; (B) axial plane.
Multiseptated cyst lesion of 4 cm located in the right posterolateral perianal region which is hyperintense in T2.
Figure 2 (A-C): Mucinous cyst of 4 cm in the right posterolateral perianal region.
After a follow-up in consultation, in 2015, recurrence of the tumor is observed, so a magnetic resonance (MR) is requested. A complex transphincteric fistula with a multiseptated cyst of 4×4 cm ( Figure 1 ) is identified. Scheduled non-oncologic surgery is performed with resection of the cyst and tutoring of the fistula with seton ( Figure 2 ). Histological examination reveals mucinous adenocarcinoma pTxR0. The immunohistochemical technique reports positivity for CK-20, Ck-7 and CDX-2, and negativity for GCDFP-15. These findings point to a mucinous adenocarcinoma within an anal fistula (with a substantial amount of mucin) isolating intestinal mucosa (Ck-20 + and CDX-2 +) and anal glands cells (CK-7+) with pagetoid extension (CK-20+ y -GCDFP-15).
In the extensive study with abdominopelvic computed tomography, colonoscopy and pelvic MR Crohn's disease with ileitis and ileo-sigmoid-bladder fistula is observed. There is not reported anorectal cancer or distant dissemination data.
On account of the locally aggressive nature of these types of tumors and after evaluating the different therapeutic options, we proceed to direct surgery in 2015. A monobloc abdominoperineal removal was carried out including intestinal and partial bladder resection. A bladder raffia was necessary to close the defect. The anatomopathological result is pT0, N0 (0/28), PN-, L/Vi-, MRC-, R0. The patient has a good post-operative evolution being discharged on the 7th postoperative day.
In 2017, he suffered several urological tract infections secondary to new ileo-bladder fistula. The MR described terminal ileitis with a fistula between the bladder and the previous intestinal anastomosis. Ileocecectomy with anastomotic resection was performed and treatment with Azathioprine 150 mg per day was established after the surgery. He is asymptomatic at present. No local or distant neoplastic disease is observed at 3 years and 11 months of follow up after the abdominoperineal, intestinal and bladder resection.
DISCUSSION
Anal cancer represents a minority of 2-3% among neoplasms of the gastrointestinal tract. 2, 5 Three types of anal canal cancer have been described: intestinal adenocarcinoma, squamous cell carcinoma, and mucinous adenocarcinoma. Only 5-11% of anal cancers correspond to anal mucinous adenocarcinoma. 2, 5 There is no consensus about its origin, pathogenesis or biological behavior. Nevertheless, there is an increase in its incidence when there are chronic concomitant inflammatory conditions such as chronic anal fistula in a patient with Crohn's disease. In 1934, Rosser et al, was a pioneer in the description of perianal carcinoma arising from chronic fistula. 3, 5 Some authors, like Traube et al, have postulated that this association is due to the need for constant regeneration of the mucosa.
It is estimated that mucinous adenocarcinoma of the anal canal has an incidence of 0.7% in patients with Crohn's disease. 2, 5, 6 If it is associated with chronic anal fistula, the average age at which it occurs is between 43 and 53 years old. The mean duration of the fistula in a patient with Crohn's disease before the diagnosis of cancer is 10-20 years. 5 The risk factors for malignization of the fistula are the degree of associated inflammation, the location, and of least importance the time of evolution. 1 Cancer often goes unnoticed owing to the inflammatory disease itself so a high diagnostic suspicion is necessary, with biopsy being the gold standard for diagnosis.
Given the anecdotal nature of the cases, there is no standardized treatment for this specific type of tumor. On one side, direct surgery is suggested in local-early stage tumors; on the other side, if the tumor is locally advanced, some case series like Gaertner et al, recommend neoadjuvant chemoradiotherapy before surgery. Occasionally, on account of the extended resection to the levator ani muscle, it is advisable to perform a pelvic floor reconstruction. 3 Radiotherapy as the only treatment is an alternative in fragile patients who cannot undergo radical surgery.
In this case, it is a localized tumor that could have been treated with the extirpation of the tumor and active surveillance. Nonetheless, in consensus with the patient and given their life expectancy and the local recurrent nature of the tumor, it was decided to perform a more aggressive treatment with oncologic direct radical surgery.
CONCLUSION
In conclusion, mucinous adenocarcinoma of the anal canal is a rare type of tumor in which a high diagnostic suspicion is necessary, especially in patients with concomitant diseases such as Crohn's disease because it may be masked. Given its local aggressiveness, it is essential to accomplish surgery with negative margins being possible to use chemoradiotherapy in a neoadjuvant way.
